At a glance
ClinicalIndex Comparison RecordN/ACompleted· 310 enrolled
Drug / intervention
Visual Acuity +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs
In Brief
An observational study evaluating Visual Acuity and Defocus Curve for Pseudophakia. Completed, enrolled 310 participants across 1 site.
Detailed Summary
Compare visual outcomes in patients with bilateral Clareon Monofocal IOLs versus bilateral Eyhance IOLs.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPseudophakia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartNov 2021
First PostedFeb 2022
Primary CompletionAug 2022
TodayJul 2026
First PostedFeb 7, 2022
Enrollment StartNov 30, 2021
Primary CompletionAug 6, 2022
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 4.4 years ago
Interventions
Visual Acuityother
Measurement of distance and intermediate visual acuity at variety targeted correction.
Defocus Curveother
Measurement of a defocus curve